102151-38-2

Upstream product

• 33469-37-3 2-(p-methoxyphenyl)-4-(trifluoromethyl)imidazole 
• 33469-37-3 2-(4-methoxyphenyl)-4-(trifluoromethyl)-imidazole 

Downstream Products

• 102151-39-3 5-bromo-2-(3-chloro-4-methoxyphenyl)-4-(trifluoromethyl)imidazole 
• 102151-41-7 4-bromo-2-(3-chloro-4-methoxyphenyl)imidazole 
• 102151-40-6 5-bromo-2-(3-chloro-4-methoxyphenyl)imidazole-4-carboxylic acid 
• 102150-87-8 (S)-4-bromo-2-<3-chloro-4-<3-<<2-(3,4-dimethoxyphenyl)ethyl>amino>-2-hydroxypropoxy>phenyl>imidazole 
• 102151-39-3 5-Bromo-2-(3-chloro-4-methoxyphenyl)-4-trifluoromethylimidazole 

Relevant academic research and scientific papers

BETA-BLOCKING SUBSTITUTED IMIDAZOLES

Novel substituted imidazoles and methods for their preparation are disclosed. These imidazoles, and their salts, exhibit pharmacological activity which includes antihypertensive activity and β-adrenergic blocking activity.

BETA-ADRENERGIC BLOCKING IMIDAZOLYLPHENOXY PROPANOLAMINES

Substituted imidazoles and methods for their preparation are disclosed. These imidazoles, and their salts, exhibit pharmacological activity which includes antihypertensive activity and β-adrenergic blocking activity. STR1

β1-Selective Adrenoceptor Antagonists: Examples of the 2-phenyl>imidazole Class. 2

An attempt to develop a highly cardioselective β-adrenoceptor antagonist devoid of intrinsic sympathomimetic activity (ISA) focused on exploring structure-activity relationships around (S)--amino>-2-hydroxypropoxy>phen